Dr. Richard Krasuski is Director of Adult Congenital Heart Disease Services and a staff cardiologist in the Section of Clinical Cardiology, Department of Cardiovascular Medicine, at Cleveland Clinic Heart and Vascular Institute.
He is certified by the American Board of Internal Medicine as Diplomate in cardiovascular disease. Dr. Krasuski's specialty interests include adult congenital heart disease including atrial septals defects, patent foramen ovale, ventricular septal defects, coarctation of the aorta, Ebstein anomaly, Eisenmenger syndrome, transposition of the great arteries, Tetralogy of Fallot and patent ductus arteriosus. He also specializes in pulmonary hypertension, mitral valve disease, cardiac catheterization, transesophageal echocardiography and mitral, aortic and pulmonic valvuloplasty.
Dr. Krasuski received his medical degree from Harvard Medical School following an undergraduate degree in biochemistry from Bowdoin College in Maine, where he graduated summa cum laude and was inducted into the honor society Phi Beta Kappa. He took his residency in internal medicine at Brigham & Women's Hospital in Boston followed by a fellowship in cardiology from Duke University Medical Center in North Carolina, which included a subspecialty in valvular heart disease and adult congenital heart disease.
Prior to his 2005 appointment to Cleveland Clinic, Dr. Krasuski served as an officer in the United States Air Force at Wilford Hall Medical Center in Texas. During this time he served an Assistant Professor of Medicine at the Uniformed Services University of Health Sciences in Washington, DC and was the clinical chair of a committee that designed educational, interactive CD-ROMs for patients with hypertension, dyslipidemia, coronary disease, congestive heart failure, and cardiac rehabilitation at the Air Force Academy in Colorado. In 2004 he was voted Researcher of the Year at Wilford Hall and was one of five physicians recognized for their academic, clinical and research expertise.
Dr. Krasuski has served as an abstract reviewer for the American College of Cardiology and has chaired various oral sessions in the past. Presently, he is a reviewer for several leading medical publications including the American Journal of Cardiology, Annals of Internal Medicine, Heart, American Journal of Managed Care, American Journal of Medicine, and the American Heart Journal.
He has authored or co-authored articles and abstracts related to his specialty interests in leading medical journals such as the Journal of the American College of Cardiology, Circulation, and the Annals of Internal Medicine.
Dr. Krasuski is a Fellow of the American College of Cardiology (FACC), and a member of the American Heart Association Clinical Cardiology Council, the American College of Physicians/American Society of Internal Medicine, the Adult Congenital Heart Association, The Pumonary Hypertension Clinicians and Researchers Society of the Pulmonary Hypertension Association and the Massachusetts Medical Society.
Watch a video about Dr. Krasuski and his views about adult congenital heart disease.
Adult congenital heart disease, cardiac catheterizatoin, echocardiography, pediatric and congenital heart surgery, valvuloplasty.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 9/4/2008, Dr. Krasuski has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Krasuski receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Actelion
- Pfizer Inc.
- Roche
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
